Marije I. Koenders
Radboud University Nijmegen Medical Centre
Nijmegen
Netherlands
Name/email consistency: high
- Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis. Koenders, M.I., Marijnissen, R.J., Devesa, I., Lubberts, E., Joosten, L.A., Roth, J., van Lent, P.L., van de Loo, F.A., van den Berg, W.B. Arthritis Rheum. (2011)
- Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Koenders, M.I., Devesa, I., Marijnissen, R.J., Abdollahi-Roodsaz, S., Boots, A.M., Walgreen, B., di Padova, F.E., Nicklin, M.J., Joosten, L.A., van den Berg, W.B. Arthritis Rheum. (2008)
- Interleukin-17 acts independently of TNF-alpha under arthritic conditions. Koenders, M.I., Lubberts, E., van de Loo, F.A., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M.M., Kolls, J.K., Di Padova, F.E., Joosten, L.A., van den Berg, W.B. J. Immunol. (2006)
- Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Koenders, M.I., Joosten, L.A., van den Berg, W.B. Ann. Rheum. Dis. (2006)
- Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Koenders, M.I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M.M., Kolls, J.K., Joosten, L.A., van den Berg, W.B. Arthritis Rheum. (2005)
- Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Koenders, M.I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M.M., Di Padova, F.E., Boots, A.M., Gram, H., Joosten, L.A., van den Berg, W.B. Am. J. Pathol. (2005)
